cancer treatment resources for breast cancer, prostate cancer and other cancer informationcancer treatment resources for breast cancer, prostate cancer and other cancer information

breast cancer treatment clinical trials for breast cancer
 
  • GW572016 for Treatment of Refractory Metastatic Breast Cancer
     
  • Paclitaxel With or Without GW572016 as First Line Therapy for Women With Advanced or Metastatic Breast Cancer
     
  • Study Comparing GW572016 and Letrozole Versus Letrozole in Subjects With Advanced or Metastatic Breast Cancer
     
  • Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced or Metastatic Breast Cancer
     
  • GW572016, An Oral Drug For Women With Refractory Metastatic Breast Cancer After First-line Or Second-line Herceptin
     
  •  

    Breast Cancer Prognosis Similar Between Women with Breast Augmentation and Those Without

    Articles
    Letrozole May Cut Risk of Breast Cancer
     
    Tesmilifene in Addition to Doxorubicin Improves Survival in Advanced Breast Cancer
     
    Doxil ® Plus Gemzar ® Active in Metastatic Breast Cancer
     
    Brachytherapy May Be Just As Effective and More Convenient than Whole Breast Radiation for Breast Cancer

    According to a recent article published in The Journal of the American Medical Association, breast augmentation decreases the ability of mammography to detect breast cancer. However, women with breast augmentation who are diagnosed with breast cancer have similar prognostic characteristics as women without breast augmentation who are diagnosed with breast cancer. 1

    Breast cancer affects over 200,000 women annually in the United States alone. When breast cancer is diagnosed and treated in its early stages, it is considered highly curable with standard therapies. However, breast cancer that has spread from its site of origin to distant and/or several sites in the body has overall poor long-term survival rates. Therefore, physicians and researchers place great emphasis on screening and prevention of breast cancer, in order to detect and treat cancer in its most curable stages or prevent the development of breast cancer altogether.

    Concern has arisen among women and physicians regarding the possibility that breast implants may interfere in the detection of breast cancer. This could result in diagnosis at a later stage and ultimately a risk of decreased survival in these women. A previous clinical study demonstrated that the diagnosis of breast cancer was not delayed in women with breast implants. 2 However, researchers continue to evaluate this issue. Recently, a multi-institutional clinical trial was conducted to further evaluate the impact of breast augmentation on the detection of breast cancer. This trial included over 800 women with breast cancer ? 137 of whom had breast augmentation, and 685 of whom did not have augmentation who were diagnosed between 1995 and 2002. Nearly 100,000 women without breast cancer were also included in the study ? 10, 533 of whom had breast augmentation and 974, 915 of whom did not have augmentation. All women underwent mammography screening.

    The ability of mammography to detect breast cancer was reduced among women with breast augmentation, compared to women without augmentation. However, prognostic factors of cancers, including estrogen-receptor status, the presence, absence or number of lymph nodes to which the cancer had spread, the extent to which the cancer had spread (stage), and the size of the cancer, were similar between women with or without breast augmentation. Women with breast augmentation tended to have less aggressive cancers.

    The researchers concluded that even though the ability to detect breast cancer is reduced by mammography in patients with breast augmentation compared those without augmentation, the prognostic factors of the cancer are similar between the two groups of women. Women with breast augmentation should discuss with their physician the most appropriate screening schedule for breast cancer for their individual case.

    References:

    1. Miglioretti D, Rutter C, Geller B, et al. Effect of Breast Augmentation on the Accuracy of Mammography and Cancer Characteristics. The Journal of the American Medical Association. 2004;291:442-450.

    2. Holmich L, Mellemkjaer L, Gunnarsdottir A, et al. Stage of breast cancer at diagnosis among women with cosmetic breast implants. British Journal of Cancer. 2003;88:832-838.

    © CancerConsultants.com
     

    cancer treatment letrozole article
     
    cancer treatment bottom line breast and prostate cancer cancer treatment bottom line right breast cancer prostate
    Home :: Clinical Trials :: Cancer Info :: Breast Cancer :: About Us :: Sitemap
    cancer treatment bottom drop shadow
    cancer treatment home page resouces on breast cancer treatment cancer clinical trials information general cancer information and resources breast cancer awareness and treatment of breast cancer about cancer treatment .com